HI
CYTK icon

Hudock Inc’s Cytokinetics CYTK Stock Holding History

Hudock Inc’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-166
Closed -$1K – 548
2014
Q3 		$1K Hold
166
– – ﹤0.01% 550
2014
Q2 		$1K Hold
166
– – ﹤0.01% 557
2014
Q1 		$2K Hold
166
– – ﹤0.01% 508
2013
Q4 		$1K Hold
166
– – ﹤0.01% 541
2013
Q3 		$1K Buy
+166
New +$1.78K ﹤0.01% 487

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hudock Inc's CYTK Position: Q4 2014 in Review

Hudock Inc sold out of Cytokinetics (CYTK) in Q4 2014, closing a stake of 166 shares — an estimated $1K sold.

Hudock Inc first reported a position in CYTK in Q3 2013 and held it in 5 quarters. The position peaked at $2K in Q1 2014. 85 funds tracked by Wall St. Rank hold CYTK as of Q4 2014.

  • Hudock Inc reported no remaining Cytokinetics position as of Q4 2014 after selling out during the quarter.
  • Hudock Inc sold 166 Cytokinetics shares in Q4 2014, an estimated $1K.
  • Hudock Inc first reported a position in Cytokinetics in Q3 2013 and held it in 5 quarters.
  • Hudock Inc's Cytokinetics position peaked at $2K in Q1 2014.
  • 85 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2014.

Based on Hudock Inc's 13F filing for Q4 2014, filed 3 Feb 2015.